EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Anaphylaxis to Proton Pump Inhibitor and SARS-CoV-2 Vaccine: What Is the Link? A Case Report and Review of the Literature

Luca Gammeri, Serena Sanfilippo, Mario Di Gioacchino, Marco Casciaro, Sebastiano Gangemi, Paola Lucia Minciullo

Allergies · 03.06.2026 · 6 (2) · 20

DOI: 10.3390/allergies6020020 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Allergies, online erschienen am 03.06.2026. Verfasst von Luca Gammeri und 5 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The widespread use of proton pump inhibitors (PPIs) in clinical practice has increased the number of related hypersensitivity reactions (HSRs). The active ingredient is not always responsible for the reaction. In some cases, HSRs may be related to the excipients contained in the drug. The adverse reactions to anti-SARS-CoV-2 vaccines have drawn the scientific community’s attention to the potential roles of excipients such as polyethylene glycol (PEG) and polysorbate 80. We present a case of a patient with three anaphylactic reactions following the administration of the anti-SARS-CoV-2 vaccine and a history of HSR to omeprazole. Through an in-depth medical history and allergy testing, we found that the patient was sensitized to PEG contained in the vaccine and to the omeprazole formulation used. We also conducted a mini-review of the literature, reporting all cases of reactions to PPIs, both related to the active ingredient and to excipients. Adverse reactions to PPIs are rare but still increasing. To our knowledge, this is the first reported case of anaphylaxis to PPI-related PEG. Some excipients are widely used in commonly used products, including non-pharmaceuticals. Therefore, in patients with multiple episodes of anaphylaxis, it appears necessary to exclude a possible allergy to excipients. This could ensure a greater safety and a better quality of life.

Zitieren

APA

Gammeri, L., Sanfilippo, S., Gioacchino, M. D., Casciaro, M., Gangemi, S., & Minciullo, P. L. (2026). Anaphylaxis to Proton Pump Inhibitor and SARS-CoV-2 Vaccine: What Is the Link? A Case Report and Review of the Literature. Allergies, 6(2), 20. https://doi.org/10.3390/allergies6020020

Vancouver

Gammeri L, Sanfilippo S, Gioacchino MD, Casciaro M, Gangemi S, Minciullo PL. Anaphylaxis to Proton Pump Inhibitor and SARS-CoV-2 Vaccine: What Is the Link? A Case Report and Review of the Literature. Allergies. 2026;6(2):20. doi:10.3390/allergies6020020

BibTeX
@article{Gammeri2026,
  author = {Gammeri, Luca and Sanfilippo, Serena and Gioacchino, Mario Di and Casciaro, Marco and Gangemi, Sebastiano and Minciullo, Paola Lucia},
  title = {Anaphylaxis to Proton Pump Inhibitor and SARS-CoV-2 Vaccine: What Is the Link? A Case Report and Review of the Literature},
  journal = {Allergies},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {20},
  doi = {10.3390/allergies6020020}
}
Kostenlos starten →